• 한국자기공명학회논문지
• /
• 제10권2호
• /
• pp.163-174
• /
• 2006

Luteinizing Hormone Releasing Hormone(LHRH) is a decapeptide neurotransmitter known to be regulated by metal ions in the hyperthalamus. Zn-binding LHRH complex was systhesized, and zinc-LHRH complex was studied to understand what kinds of structural modifications would be critical in the LHRH releasing mechanism. Both nonexchangeable and exchangeable $^1H-NMR$ signal assignments were accomplished by pH-dependent and COSY NMR experiments. In addition, $^1H-NMR$ chemical shift changes of a-proton and peptide NH NMR signals at different pH condition, and $^1H-NMR$ signal differences between metal free and metallo-LHRH complex was monitored. NMR signals exhibit that primary metal-binding sites are nitrogens donor of imidazole ring and Arg, and peptide oxygen of Pro-His in the sequence. Structure obtained in this study has a cyclic conformation which is similar to that of energy minimized, and exhibits a specific a-helical turn with residue numbers $(2{\sim}7)$ out of 10 amino acids.

• 한국발생생물학회지:발생과생식
• /
• 제24권3호
• /
• pp.149-158
• /
• 2020

Kisspeptin, expressed mainly in the hypothalamus, stimulates gonadotropin-releasing hormone neurons to facilitate reproduction. In some model animals, the kisspeptin is also expressed in the pituitary. Recently, a pathway has been suggested in which kisspeptin acts directly on the pituitary to secretion of gonadotropin in mammals. In the present study, pituitaries of the Nile tilapia (Oreochromis niloticus) were cultured at different concentrations of kisspeptin-10 (Kp-10, FNYNPLSLRF) for 3 hours to observe the effect of kisspeptin on the expression of follicle-stimulating hormone β subunit (fshβ) gene and luteinizing hormone β subunit (lhβ) gene. Pituitary tissues were cultured with 0.1 μM of Kp-10, luteinizing hormone releasing hormone (LHRH), or LHRH+Kp-10 for 3, 6, 12, and 24 hours to investigate changes in the expression of fshβ and lhβ mRNA. Pituitaries cultured with high concentration of Kp-10 more than 0.1 μM for 3 hours exhibited a significant increase of fshβ mRNA expression, but not lhβ mRNA. The expression of both fshβ and lhβ mRNA increased after 6 hours in 0.1 μM of Kp-10 medium in comparison with that in the control medium. Tissues cultured in the LHRH medium however exhibited increased expression of both genes not only at 6 but also 12 hours. There were no significant differences of fshβ and lhβ gene expression in tissues cultured with LHRH+KP-10 medium compared with the control. These results suggested that although kisspeptin plays an important role in fshβ and lhβ expression in the pituitary of Nile tilapia, its action is far more complicated than expected.

• Journal of Breast Disease
• /
• 제6권2호
• /
• pp.46-51
• /
• 2018

Purpose: Endocrine therapy is the preferred treatment for hormone receptor (HR)-positive metastatic breast cancer (MBC). We investigated the efficacy of combined aromatase inhibitor (AI) and luteinizing hormone-releasing hormone (LHRH) agonist in premenopausal patients with HR-positive MBC. Methods: We retrospectively analyzed the medical records of 21 HR-positive premenopausal MBC patients treated with combined AI and LHRH agonist therapy. Results: The median follow-up period was 32.9 months. The overall response rate was 47.6%, with three complete responses (14.3%) and seven partial responses (33.3%). Nine patients (42.9%) achieved stable disease lasting more than 6 months; thus, the clinical benefit rate was 90.4%. The median time to progression was 45.4 months. No patients experienced grade 3 or 4 toxicity. Conclusion: Combined AI and LHRH agonist treatment safely and effectively induced remission or prolonged disease stabilization, suggesting that this could be a promising treatment option for HR-positive premenopausal patients with MBC.

• Journal of Microbiology and Biotechnology
• /
• 제24권9호
• /
• pp.1291-1299
• /
• 2014

Recently, multifunctional nanomaterials have been developed as nanotherapeutic agents for cellular imaging and targeted cancer treatment because of their ease of synthesis and low cytotoxicity. In this study, we developed a multifunctional, two-component nanorod consisting of gold (Au) and nickel (Ni) blocks that enables dual-fluorescence imaging and the targeted delivery of small interfering RNA (siRNA) to improve cancer treatment. Fluorescein isothiocyanate-labeled luteinizing hormone-releasing hormone (LHRH) peptides were attached to the surface of a Ni block via a histidine-tagged LHRH interaction to specifically bind to a breast cancer cell line, MCF-7. The Au block was modified with TAMRA-labeled thiolated siRNA in order to knock down the vascular endothelial growth factor protein to inhibit cancer growth. These two-component nanorods actively targeted and internalized into MCF-7 cells to induce apoptosis through RNA interference. This study demonstrates the feasibility of using two-component nanorods as a potential theranostic in breast cancer treatment, with capabilities in dual imaging and targeted gene delivery.

• Clinical and Experimental Reproductive Medicine
• /
• 제21권1호
• /
• pp.43-48
• /
• 1994

To evaluate the effectiveness of GnRH agonist for the treatment of uterine myoma as a cause of infertility, fourteen women were recruited to the study. The patients were treated with a delayed-release formulation of D-$Trp^6$-LHRH in biodegradable microcapsules(Decapeptyl-CR), administered intramuscularly at four week intervals for a period of six monthes. The first injection was given on day 21 of the cycle. Serum estradiol levels fell significantly to the mean value of 257.7pgjml 4 weeks after the first injection. Eleven patients in fourteen treated patients had a reduction in the size of uterine myoma as assessed by ultrasonography, two patients had no change of size and one patient had a increase of size. After the first or second injection, all patients became amenorrheic, then resumption of menstruation ocurred at 12 to 14 weeks after the last injection. Common side effects were hot flush, sweating and dyspareunia, whitch were acceptale. In Eleven patients who had a reduction in the size of uterine myoma by treatment with a delayed- release formulation of D-$Trp^6$-LHRH(Decapeptyl-CR), after above treatment with GnRH agonist, then four patients were treated with myomectomy, three patients had pregnancy and full term delivered by Cesarean section. These data suggest that administration of a delayed-release formulation of a GnRH agonist can be a worthwhile and convenient approach to the medical treatment of uterine myoma as a cause of infertility.

• Asian-Australasian Journal of Animal Sciences
• /
• 제2권1호
• /
• pp.39-42
• /
• 1989

Eighteen multiparous and 8 nulliparous cows with cystic ovarian disease (19 having follicular cysts, 7 with luteal cysts) were administered either 3000 I. U. HCG or $300{\mu}g$ LHRH. Ten animals responded satisfactorily leading to normal estrus within a period of 15 to 30 days and subsequent conception. In 8 animals cysts recurred and no effect of treatment was observed in 3 patients. Plasma progesterone concentration was significantly lower in animals having follicular cysts compared to those with luteal cysts.

• Asian-Australasian Journal of Animal Sciences
• /
• 제5권2호
• /
• pp.337-339
• /
• 1992

Successful induction of lactation in 5 nulliparous repeat breeding cows was achieved by administering diethyl stillboestrol (0.1 mg/kg B.W.) and hydroxyprogesterone caproate (0.25 mg/kg B.W.) for 3 days followed by reserpine (4 mg/day) for 4 days, and dexamethasone (16 mg/day) for one day. The treatment caused cystic ovarian condition in all the animals. Intravaginally progesteronesoaked sponges suppressed but did not eliminate the behavioural estrus. Administration of LHRH ($300{\mu}g$) regressed the cysts in all animals in the first instance but the cysts reappeared in 2 animals. One animal became pregnant and delivered a normal calf.

• Clinical and Experimental Pediatrics
• /
• 제46권4호
• /
• pp.400-403
• /
• 2003

진단이 지연되었거나 적절하게 치료되지 않은 선천성 부신 과형성증을 가진 남아에서 장기간 고농도의 남성호르몬에 노출될 경우 처음에는 가성 성조숙증이었다가 이후 진성 성조숙증으로 전환될 수 있으므로 선천성 부신 과형성증의 조기진단과 치료가 필요하다. 저자들은 가성 성조숙증에서 진성 성조숙증으로 전환된 선천성 부신 과형성증을 가진 남아에서 hydrocortisone과 GnRH 유도체를 사용하여 큰 부작용 없이 2차 성징의 퇴축을 가져온 1례를 경험하고 문헌고찰과 함께 보고하는 바이다.

• 한국양식학회:학술대회논문집
• /
• 한국양식학회 2003년도 추계학술발표대회 논문요약집
• /
• pp.62-62
• /
• 2003

최근 연안 자원이 급격하게 감소하고 있고 새로운 양식 대상종으로 평가되고 있는 말쥐치의 대량 종묘생산을 위해서는 수정난 대량확보와 자어기 먹이생물 구명 등의 문제점이 해결되어야 한다. 본 연구자들은 우선 호르몬 처리에 의한 산란유도, 조기성숙유도에 의한 조기산란유도 및 수정난 확보방법을 개발하고, 위내용물 분석을 통한 자어의 초기먹이생물을 구명하고자 하였다. 산란유도를 위하여 hCG, LHRH-a 및 hCG+LHRH-a를 다양한 농도로 처리하여 실험한 결과 모든 실험구에서 67~76%의 수정률을 나타내었으나, 대량의 성숙란을 얻지는 못하였다. 따라서 본 종의 산란특성이 다회성인 점을 감안한다면 500 g 전후의 친어 200~300마리를 1개의 수조에 수용하여 자연산란된 수정란을 수거하는 것이 좋을 것으로 판단되었다. 평균 450 g 정도의 말쥐치 친어를 12월부터 6개월동안 천천히 수온을 상승시켜 자연산란을 유도한 결과, 자연산란기 (6월)보다 2개월 빠른 4월 15일(17$^{\circ}C$로 가온한 지 15일)에 첫 산란이 이루어졌고 1개월간 지속되었다. 초기 사육환경을 구명하기 위한 실험에서는 일반적으로 해산어 종묘 생산에 이용하는 클로렐라＋rotifer 실험군이 클로렐라 단독, 규조류 단독, 규조＋rotifer, 녹조＋copepods등이 번식된 환경보다 생존율에 있어 월등히 높은 결과를 나타내었다. 위 내용물 분석에 의한 사육기간 중 섭식한 주요 먹이생물종은 부화 후 5일부터 20일째까지는 rotifer egg, 부화 10일째는 rotifer egg와 small rotifer, 부화 20일째는 rotifer, Artemia sp., copepods, 부화 25일째부터는 copepods였다. 초기성장은 부화직후 전장 1.95 mm였던 것이 10일째는 2.96 mm, 20일째는 3.89 mm, 30일째는 12.9 mm, 50일째는 35.1 mm를 나타내었다. 그러나 말쥐치 자ㆍ치어가 성장함에 따라 발생하는 지속적인 폐사와 종묘의 수송시 발생하는 폐사를 줄일 수 있는 방법이 추후에 해결되어야 할 것으로 사료된다.

• 한국어류학회지
• /
• 제21권1호
• /
• pp.15-22
• /
• 2009

성숙한 왕종개 Iksookimia longicorpa를 2007년 6월에 전라북도 남원시 운봉읍에서 채집하여 난발생과 초기생활사를 연구하였다. 채집된 성숙한 개체는 LHRH를 주사하였으며 건식법으로 수정시켰다. 성숙란은 분리침성란으로 밝은 노란색이었으며 난경은 평균 $1.53{\pm}0.07mm$였다. 수온 $23{\sim}25^{\circ}C$에서 수정 후 50~72시간 사이에 부화하였으며 크기는 전장 $5.1{\pm}0.23mm$였다. 부화 후 4일경에 난황이 거의 흡수 되었고 전장 $7.1{\pm}0.47mm$로 성장하였다. 부화 후 25일 경에 지느러미 기조가 모두 정수로 되어 치어기에 달하였으며 전장 $12.8{\pm}0.49mm$로 성장하였다. 부화 후 100일 후에 반문모양과 외부형태가 성어와 유사하였으며 전장 $38.5{\pm}2.95mm$로 성장하였다.